231 related articles for article (PubMed ID: 29986618)
21. Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract.
Susan SH; Ng SB; Wang S; Tan SY
Semin Diagn Pathol; 2021 Jul; 38(4):21-30. PubMed ID: 34016481
[TBL] [Abstract][Full Text] [Related]
22. Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830926
[TBL] [Abstract][Full Text] [Related]
23. Lymphoproliferative Disorders of the Gastrointestinal Tract.
Skinnider BF
Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
25. Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopy.
Nagaishi T; Yamada D; Suzuki K; Fukuyo R; Saito E; Fukuda M; Watabe T; Tsugawa N; Takeuchi K; Yamamoto K; Arai A; Ohtsuka K; Watanabe M
Clin J Gastroenterol; 2019 Oct; 12(5):434-440. PubMed ID: 30968266
[TBL] [Abstract][Full Text] [Related]
26. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
Owens SR
Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
[TBL] [Abstract][Full Text] [Related]
27. NK cell enteropathy: a case report with 10 years of indolent clinical behaviour.
Isom JA; Arroyo MR; Reddy D; Joshi-Guske P; Al-Quran SZ; Li Y; Allan RW
Histopathology; 2018 Aug; 73(2):345-350. PubMed ID: 29474745
[TBL] [Abstract][Full Text] [Related]
28. Lymph node involvement by enteropathy-like indolent NK-cell proliferation.
Dargent JL; Tinton N; Trimech M; de Leval L
Virchows Arch; 2021 Jun; 478(6):1197-1202. PubMed ID: 32696224
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases].
Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039
[No Abstract] [Full Text] [Related]
30. CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.
Weng CY; Ye C; Fan YH; Lv B; Zhang CL; Li M
World J Clin Cases; 2022 May; 10(15):4971-4984. PubMed ID: 35801019
[TBL] [Abstract][Full Text] [Related]
31. Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma.
Shiozawa E; Saito B; Yamochi-Onizuka T; Makino R; Takimoto M; Nakamaki T; Tomoyasu S; Ota H
Pathol Int; 2007 Oct; 57(10):688-93. PubMed ID: 17803658
[TBL] [Abstract][Full Text] [Related]
32. Is ALK-gene rearrangement overlooked in primary gastrointestinal T-cell lymphomas? About two cases.
Mneimneh WS; Vyas SG; Cheng L; Cummings OW; Czader M
Pathol Int; 2015 Dec; 65(12):666-70. PubMed ID: 26531107
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach.
Pizzi M; Sabattini E; Parente P; Bellan A; Doglioni C; Lazzi S
Pathologica; 2020 Sep; 112(3):227-247. PubMed ID: 33179624
[TBL] [Abstract][Full Text] [Related]
34. Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report.
Goto R; Kawamura N; Watanabe M; Koshizuka Y; Shiratori S; Ara M; Honda S; Mitsuhashi T; Matsuno Y; Shimamura T; Taketomi A
Surg Case Rep; 2020 Jun; 6(1):147. PubMed ID: 32588353
[TBL] [Abstract][Full Text] [Related]
35. Indolent T-Cell Lymphoproliferative Disorder of the Uterine Corpus: A Case Report.
Thomas SJ; Morley N; Lashen H; Naresh KN; Fernando M
Int J Gynecol Pathol; 2020 Sep; 39(5):503-506. PubMed ID: 31567541
[TBL] [Abstract][Full Text] [Related]
36. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and molecular features of indolent natural killer-cell lymphoproliferative disorder of the gastrointestinal tract.
Yi H; Li A; Ouyang B; Da Q; Dong L; Liu Y; Xu H; Zhang X; Zhang W; Jin X; Gu Y; Wang Y; Liu Z; Wang C
Histopathology; 2023 Mar; 82(4):567-575. PubMed ID: 36494712
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
39. The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms.
Matutes E
Int J Lab Hematol; 2018 May; 40 Suppl 1():97-103. PubMed ID: 29741263
[TBL] [Abstract][Full Text] [Related]
40. Update on the Classification of and Diagnostic Approaches to Mature T-Cell Lymphomas.
Zhang X; Zhou J; Han X; Wang E; Zhang L
Arch Pathol Lab Med; 2022 Aug; 146(8):947-952. PubMed ID: 34524423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
